Our Focus
Our unique sector focus means we are always aware of the latest biosimilars industry developments and have access to unrivalled networks within the sector.
The European market is expected to continue to mature and the US offers opportunities, despite many practical challenges. On both sides of the Atlantic, however, downward price pressure suggests competition will be intense.
